A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.
Clinical trial NCT07016997 · RECRUITING
Trial details
- NCT number
- NCT07016997
- Sponsor
- Chiome Bioscience Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-27
- Primary completion
- 2025-12-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.